학술논문
Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working Party.
Document Type
Report
Author
de Witte MA; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Mooyaart JE; EBMT Statistical Unit, Leiden, The Netherlands.; Hoogenboom JD; EBMT Leiden Study Unit, Leiden, The Netherlands.; Chabannon C; Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapies, Université d'Aix-Marseille, Inserm, CBT 1409, Marseille, France.; Malard F; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), INSERM, Paris, France.; Ruggeri A; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy.; Kuball J; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands. j.h.e.kuball@umcutrecht.nl.
Source
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Subject
Language
English